Clotrimazole

BRAND NAMES

• Canesten (Bayer) – one of the most widely used global brands

• Lotrimin (especially in the United States)

• Desenex (primarily for antifungal powders/sprays in some markets)

MECHANISM OF ACTION

Clotrimazole is an antifungal medication that works by inhibiting the fungal enzyme lanosterol 14α-demethylase, which is essential for ergosterol synthesis. By blocking ergosterol production, it disrupts the integrity of the fungal cell membrane, increasing permeability and ultimately stopping fungal growth or causing cell death.

PHARMACOKINETICS

Absorption

Clotrimazole has minimal systemic absorption when applied topically or intravaginally. Most of the drug remains localized at the site of application (skin or mucosa), where it exerts its antifungal effect. Only a very small amount is absorbed into the bloodstream, which is rapidly metabolized in the liver, contributing to its generally low risk of systemic side effects.

Distribution

Clotrimazole has a very large volume of distribution (greater than 10 L/kg), meaning it extensively distributes into body tissues due to its high lipophilicity and remains at very low levels in plasma.

Metabolism

Clotrimazole is mainly metabolized in the liver through oxidation and reduction pathways, primarily involving cytochrome P450 enzymes. It undergoes breakdown into inactive metabolites, which are then further processed before elimination. Because systemic absorption is low, overall metabolic load is limited during topical use.

Elimination

Clotrimazole is eliminated mainly through hepatic metabolism, and its metabolites are excreted predominantly in the feces via the bile, with only a small fraction excreted in urine. Due to its low systemic absorption when used topically, overall elimination from the body occurs slowly and at low concentrations.

PHARMACODYNAMICS

Clotrimazole is a fungistatic antifungal that inhibits the synthesis of ergosterol by blocking the enzyme lanosterol 14α-demethylase. This leads to disruption of fungal cell membrane structure and function, increasing membrane permeability and causing leakage of essential cellular components. At higher concentrations, it can also exert fungicidal effects, resulting in fungal cell death.

ADMINISTRATION

Clotrimazole is administered primarily by topical and local routes, including creams, lotions, powders, and solutions for skin infections, and vaginal tablets or creams for vulvovaginal candidiasis. It is applied directly to the affected area 2–3 times daily for cutaneous infections, while intravaginal formulations are usually used once daily for a prescribed duration, depending on the severity of infection. Oral formulations are not commonly used due to poor systemic absorption.

DOSAGE AND STRENGTH

Clotrimazole is available in several strengths depending on the formulation. Topical creams are commonly available as 1% and 2% w/w, while powders and solutions are usually 1%. Vaginal formulations include 1% cream, 2% cream, and vaginal tablets such as 100 mg, 200 mg, and 500 mg single-dose or multi-day regimens. The exact dosage and duration depend on the type and severity of the fungal infection being treated.

DRUG INTERACTIONS

Clotrimazole has relatively few clinically significant drug interactions when used topically due to minimal systemic absorption. However, when absorbed, it may inhibit cytochrome P450 enzymes and theoretically increase the levels of drugs metabolized by these enzymes. Concurrent use with other topical antifungals or corticosteroids may alter local effectiveness. Overall, meaningful systemic drug interactions are rare with standard topical or intravaginal use.

FOOD INTERACTIONS

Clotrimazole has no significant food interactions because it is primarily used topically or intravaginally and has minimal systemic absorption. Food intake does not affect its absorption, efficacy, or safety in clinical use.

CONTRAINDICATIONS

1. Check allergy history – Do not use if the patient has a known hypersensitivity to clotrimazole or other imidazole antifungals.

2. Assess previous reactions – Avoid if there has been past severe skin irritation, rash, itching, swelling, or anaphylaxis after use.

3. Pregnancy consideration – Vaginal formulations should be avoided during the first trimester unless specifically advised by a healthcare provider.

4. Skin condition check – Do not apply on areas with severe unexplained skin reactions or undiagnosed lesions without medical advice.

5. Medical supervision – Use cautiously in special populations (e.g., pregnancy or recurrent infections) under healthcare guidance.

SIDE EFFECTS

• Skin irritation

• Redness

• Itching

• Burning or stinging sensation

• Allergic skin rash

• Swelling (rare)

• Increased vaginal discharge (with vaginal use)

• Local discomfort (vaginal use)

OVER DOSE

• Overdose is rare due to minimal systemic absorption 

• Excess topical use may cause local irritation 

• Redness and burning at application site 

• Itching or skin discomfort 

• Accidental ingestion may cause nausea 

TOXICITY

Clotrimazole has low systemic toxicity because it is poorly absorbed when applied topically or intravaginally. Toxic effects are uncommon, but excessive use may cause local irritation such as redness, burning, or itching. In cases of accidental ingestion, especially in large amounts, mild gastrointestinal symptoms like nausea, vomiting, and abdominal discomfort may occur, but serious systemic toxicity is rare.